Next Article in Journal
The Use of Donor-Derived Cell-Free DNA for Assessment of Allograft Rejection and Injury Status
Next Article in Special Issue
Endometriosis and the Fallopian Tubes: Theories of Origin and Clinical Implications
Previous Article in Journal
Use of Biosimilar Follicle-Stimulating Hormone in Asthenozoospermic Infertile Patients: A Multicentric Study
Previous Article in Special Issue
Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis
 
 
Review

The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids

1
Second Department of Obstetrics and Gynecology, The Center of Postgraduate Medical Education, 01-809 Warsaw, Poland
2
Department of Surgery, University of Illinois at Chicago, Chicago, IL 60612, USA;[email protected]
3
Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, 11566 Cairo, Egypt
4
School of Public Health, University of Illinois at Chicago, Chicago, IL 60612, USA
5
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Illinois at Chicago, Chicago, IL 60612, USA
6
Moscow Region Cancer Center, Balashikha 143900, Russian
7
Department of Internal Diseases and Endocrinology, Central Teaching Clinical Hospital, Medical University of Warsaw, 02-097 Warsaw, Poland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2020, 9(5), 1479; https://doi.org/10.3390/jcm9051479
Received: 21 April 2020 / Revised: 11 May 2020 / Accepted: 11 May 2020 / Published: 14 May 2020
(This article belongs to the Special Issue Diagnosis and Management of Endometriosis and Uterine Fibroids)
Uterine fibroids (UFs) remain a significant health issue for many women, with a disproportionate impact on women of color, likely due to both genetic and environmental factors. The prevalence of UFs is estimated to be approximately 70% depending on population. UF-derived clinical symptoms include pelvic pain, excessive uterine bleeding, gastrointestinal and voiding problems, as well as impaired fertility. Nowadays numerous methods of UF treatment are available—from conservative treatment to invasive surgeries. Selecting an appropriate treatment option should be individualized and adjusted to the patient's expectations as much as possible. So far, the mainstay of treatment is surgery, but their negative impact of future fertility is clear. On the other hand, emerging new pharmaceutical options have significant adverse effects like liver function impairment, hot flashes, bone density loss, endometrial changes, and inability to attempt conception during treatment. Several natural compounds are found to help treat UFs and relieve their symptoms. In this review we summarize all the current available data about natural compounds that may be beneficial for patients with UFs, especially those who want to preserve their future fertility or have treatment while actively pursuing conception. Vitamin D, epigallocatechin gallate, berberine, curcumin, and others are being used as alternative UF treatments. Moreover, we propose the concept of using combined therapies of natural compounds on their own or combined with hormonal agents to manage UFs. There is a strong need for more human clinical trials involving these compounds before promoting widespread usage. View Full-Text
Keywords: uterine fibroid; leiomyoma; vitamin D; epigallocatechin gallate; natural; therapy; pharmacotherapy; phytotherapy; prevention; diet uterine fibroid; leiomyoma; vitamin D; epigallocatechin gallate; natural; therapy; pharmacotherapy; phytotherapy; prevention; diet
Show Figures

Figure 1

MDPI and ACS Style

Ciebiera, M.; Ali, M.; Prince, L.; Jackson-Bey, T.; Atabiekov, I.; Zgliczyński, S.; Al-Hendy, A. The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids. J. Clin. Med. 2020, 9, 1479. https://doi.org/10.3390/jcm9051479

AMA Style

Ciebiera M, Ali M, Prince L, Jackson-Bey T, Atabiekov I, Zgliczyński S, Al-Hendy A. The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids. Journal of Clinical Medicine. 2020; 9(5):1479. https://doi.org/10.3390/jcm9051479

Chicago/Turabian Style

Ciebiera, Michał, Mohamed Ali, Lillian Prince, Tia Jackson-Bey, Ihor Atabiekov, Stanisław Zgliczyński, and Ayman Al-Hendy. 2020. "The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids" Journal of Clinical Medicine 9, no. 5: 1479. https://doi.org/10.3390/jcm9051479

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop